GlassScriptPhysician profile
Ruth Tomita
NPI 1508824129
$865.62
in general payments reported to CMS, 2019-2025
16 companies · $86.98 in 2025
The $86.98 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $122 · 2021: $139 · 2022: $148 · 2023: $68.61 · 2024: $153 · 2025: $86.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $178.31 | 2019-2023 | Pediarix, Bexsero, Shingrix |
| Astellas Pharma US INC | $176.39 | 2023-2025 | Veozah |
| Abbvie INC. | $153.28 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $59.51 | 2019-2025 | Aptima |
| Olympus America INC. | $47.96 | 2019-2021 | |
| Myovant Sciences INC. | $46.27 | 2022 | |
| Lilly USA, LLC | $33.93 | 2021-2025 | Zepbound |
| Allergan, INC. | $32.97 | 2019-2020 | |
| Pfizer INC. | $27.49 | 2019 | |
| Merck Sharp & Dohme LLC | $26.67 | 2024 | Gardasil, Vaxneuvance, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $17.63 | 2025 | |
| Therapeuticsmd, INC. | $17.27 | 2022 | |
| Medtronic, INC. | $14.97 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.64 | 2021 | |
| Amarin Pharma, INC. | $12.36 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $6.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Tomita listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.